http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104188983-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ac31afbea1cbbb03498644721ffb4a62 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58 |
| filingDate | 2014-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_719b0310d7da41ad2fcd37b6576318a2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_20afed6065891e7b6edbf50fb9ea5cc9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6719bdc3539ebadeb0d18fa03da0ac3 |
| publicationDate | 2014-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104188983-A |
| titleOfInvention | Application of Cleistanone O-(morpholinyl)ethyl derivative in preparation of heart failure resisting drugs |
| abstract | The invention relates to the field of organic synthesis and pharmaceutical chemistry and particularly relates to a Cleistanone O-(morpholinyl)ethyl derivative, a preparation method thereof and application thereof in the preparation of heart failure resisting drugs. According to the invention, a novel Cleistanone O-(morpholinyl)ethyl derivative is synthesized, and a preparation method of the novel Cleistanone O-(morpholinyl)ethyl derivative is disclosed. Shown by pharmacological experiments, the Cleistanone O-(morpholinyl)ethyl derivative disclosed by the invention has a heart failure resisting effect and has a value in the development of the heart failure resisting drugs. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104814968-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104887665-A |
| priorityDate | 2014-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 26.